BI-L-357
BI-L-357 is a succinate derived from BI-L-226 that acts as a precursor, enhances oral bioavailability and inhibits 5-lipoxygenase-mediated leukotriene production[1].
Product Specifications
CAS Number
[149539-02-6]
UNSPSC
12352005
Target
Lipoxygenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bi-l-357.html
Smiles
O=C(CCC(O)=O)OC1=C(C=C(C=C1C)/C=C/C2=CC=CS2)C
Molecular Formula
C18H18O4S
Molecular Weight
330.40
References & Citations
[1]A prodrug of a 2,6-disubstituted 4- (2-arylethenyl) phenol is a selective and orally active 5-lipoxygenase inhibitor.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15316651 1 Vial
Lentiviral human ACYP2 shRNA (UAS) - Lentiviral human ACYP2 shRNA (UAS, iRFP) plasmid
Ask
View Details 
477091 100 µL
CAPSL (Calcyphosine-Like, Calcyphosine-Like (Predicted) EMBL EDL75667.1)
Ask
View Details 